Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director · Chairman and CEO | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 62,442 |
Reported balance
After 2026-09-15 transaction · row 1
1 source rowRow 1 · 2026-09-15 · Grant · Acquired 21,812 · Balance 62,442 F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 17, 2026 20:21 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 21,812 | $275.09 | $6,000,263.08 |
DisclosureSEC source: 0001212809-26-000008 · wk-form4_1789676469.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,442 F1 · kind: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 21:17 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 628 | $275.03 | $172,718.84 |
DisclosureSEC source: 0001212809-26-000006 · wk-form4_1789161450.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,630 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.9056 to $275.0804, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 10, 2026 Filed Sep 11, 2026 21:17 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 14,372 | $274.41 | $3,943,820.52 |
DisclosureSEC source: 0001212809-26-000006 · wk-form4_1789161450.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,258 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.875 to $274.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:12 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 9,004 | $299.58 | $2,697,418.32 |
DisclosureSEC source: 0001212809-26-000004 · wk-form4_1779135132.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,630 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $299.00 to $299.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 15, 2026 Filed May 18, 2026 20:12 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 25,996 | $298.14 | $7,750,447.44 |
DisclosureSEC source: 0001212809-26-000004 · wk-form4_1779135132.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,634 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $298.00 to $298.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:23 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 27,866 | $311.40 | $8,677,472.40 |
DisclosureSEC source: 0001628280-26-018541 · wk-form4_1773764625.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,630 F2 · shares: Mr. Duffy surrendered shares to the company in order to fulfill tax withholding obligations related to the receipt of the performance share award. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 16:23 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 62,902 | $311.40 | $19,587,682.80 |
DisclosureSEC source: 0001628280-26-018541 · wk-form4_1773764625.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,496 F1 · shares: Represents the vesting of performance shares granted in 2022 under CME Group's Omnibus Stock Plan. The number of shares was determined based on the company's achievement of total shareholder return relative to the S&P 500 measured over a three-year performance period from January 1, 2023 through December 31, 2025. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 19:28 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 10,210 | $273.08 | $2,788,146.80 |
DisclosureSEC source: 0001628280-26-000083 · wk-form4_1767382112.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,594 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2025. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 20:05 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 11,911 | $270.05 | $3,216,565.55 |
DisclosureSEC source: 0001628280-25-056950 · wk-form4_1765829120.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,804 F1 · price: On December 11, 2025, Mr. Duffy sold an aggregate of 25,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $268.66 to $269.66 for 13,809 shares and $269.68 to $270.51 for 11,911 shares. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 20:05 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 13,089 | $269.10 | $3,522,249.90 |
DisclosureSEC source: 0001628280-25-056950 · wk-form4_1765829120.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,715 F1 · price: On December 11, 2025, Mr. Duffy sold an aggregate of 25,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $268.66 to $269.66 for 13,809 shares and $269.68 to $270.51 for 11,911 shares. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 17:48 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 23,180 | $258.83 | $5,999,679.40 |
DisclosureSEC source: 0001212809-25-000005 · wk-form4_1758131297.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,804 Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:19 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 11,468 | $258.68 | $2,966,542.24 |
DisclosureSEC source: 0001156375-25-000053 · wk-form4_1742314736.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,624 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 16:19 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 25,887 | $258.68 | $6,696,449.16 |
DisclosureSEC source: 0001156375-25-000053 · wk-form4_1742314736.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,092 F1 · shares: For the PSAs granted in September 2021: Represents shares earned from a 2021 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2022-2024. Read SEC document |
| March 11, 2025 Filed Mar 11, 2025 20:44 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 30,000 | $259.18 | $7,775,400.00 |
DisclosureSEC source: 0001156375-25-000031 · wk-form4_1741725855.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,205 F1 · price: On March 11, 2025, Mr. Duffy sold an aggregate of 30,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $259.00 to $259.26. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 01:06 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 11,706 | $232.23 | $2,718,484.38 |
DisclosureSEC source: 0001156375-25-000002 · wk-form4_1735866405.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,205 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2024. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 23:10 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 27,456 | $218.53 | $5,999,959.68 |
DisclosureSEC source: 0001156375-24-000168 · wk-form4_1726614595.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,911 Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 25,216 | $211.44 | $5,331,671.04 |
DisclosureSEC source: 0001156375-24-000074 · wk-form4_1714597589.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,455 F3 · price: The price reported in column four is a weighted average price. These shares were sold in multiple transactions at prices ranging from $211.00 to $211.8932, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, with full information regarding the number of shares sold at each separate price within this above range. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 10,708 | $210.20 | $2,250,821.60 |
DisclosureSEC source: 0001156375-24-000074 · wk-form4_1714597589.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,671 F2 · price: The price reported in column four is a weighted average price. These shares were sold in multiple transactions at prices ranging from $210.00 to $210.45, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, with full information regarding the number of shares sold at each separate price within this above range. Read SEC document |
| April 29, 2024 Filed May 1, 2024 21:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 4,076 | $209.52 | $854,003.52 |
DisclosureSEC source: 0001156375-24-000074 · wk-form4_1714597589.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,379 F1 · price: The price reported in column four is a weighted average price. These shares were sold in multiple transactions at prices ranging from $209.485 to $209.64, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, with full information regarding the number of shares sold at each separate price within this above range. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:24 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 20,095 | $217.50 | $4,370,662.50 |
DisclosureSEC source: 0001156375-24-000048 · wk-form4_1710861835.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,455 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 15:24 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 45,359 | $217.50 | $9,865,582.50 |
DisclosureSEC source: 0001156375-24-000048 · wk-form4_1710861835.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,550 F1 · shares: Represents shares earned from a 2020 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2021-2023. Read SEC document |
| December 31, 2023 Filed Jan 2, 2024 18:57 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 12,366 | $210.60 | $2,604,279.60 |
DisclosureSEC source: 0001156375-24-000002 · wk-form4_1704221825.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,191 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2023. The closing price of CME Group Class A common stock on 12/29/2023 was used as 12/31/2023 was not a trading day. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:04 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 29,012 | $206.82 | $6,000,261.84 |
DisclosureSEC source: 0001156375-23-000146 · wk-form4_1695074688.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,557 Read SEC document |
| August 18, 2023 Filed Aug 21, 2023 20:20 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 30,000 | $203.95 | $6,118,500.00 |
DisclosureSEC source: 0001156375-23-000143 · wk-form4_1692649191.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,545 F1 · price: On August 18, 2023, Mr. Duffy sold an aggregate of 30,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within $1 range have been aggregated and the weighted average has been reported. The price range was $203.82 to $204.18. The Company maintains a record of the transaction and copies will be provided upon request. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 21:37 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 13,364 | $168.16 | $2,247,290.24 |
DisclosureSEC source: 0001156375-23-000002 · wf-form4_167278184066358.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,545 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2022. F2 · price: The closing price of December 30, 2022 was used for purposes of calculating the number of shares surrendered as the actual vesting date was a non-trading day. Read SEC document |
| December 31, 2022 Filed Jan 3, 2023 21:37 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 7,167 | $168.16 | $1,205,202.72 |
DisclosureSEC source: 0001156375-23-000002 · wf-form4_167278184066358.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,909 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2022. F2 · price: The closing price of December 30, 2022 was used for purposes of calculating the number of shares surrendered as the actual vesting date was a non-trading day. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:26 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 2,514 | $190.77 | $479,595.78 |
DisclosureSEC source: 0001156375-22-000275 · wf-form4_166362633800531.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,076 F1 · shares: Mr. Terrence Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2022. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:26 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 31,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-22-000275 · wf-form4_166362633800531.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,590 Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:45 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 4,638 | $232.00 | $1,076,016.00 |
DisclosureSEC source: 0001156375-22-000136 · wf-form4_164754991523869.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,138 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 20:45 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 10,468 | $232.00 | $2,428,576.00 |
DisclosureSEC source: 0001156375-22-000136 · wf-form4_164754991523869.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,776 F1 · shares: Represents shares earned from a 2018 performance share award based on the company's achievement of total shareholder return relative to the S&P 500 measured over 2019-2021. Read SEC document |
| November 05, 2021 Filed Nov 8, 2021 20:57 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 400 | $222.02 | $88,806.40 |
DisclosureSEC source: 0001156375-21-000171 · wf-form4_163640506375000.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,308 Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:03 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 600 | $220.26 | $132,153.00 |
DisclosureSEC source: 0001156375-21-000169 · wf-form4_163612457390592.xml · nonDerivative · entry 6 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,908 Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:03 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 100 | $220.20 | $22,020.00 |
DisclosureSEC source: 0001156375-21-000169 · wf-form4_163612457390592.xml · nonDerivative · entry 5 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,308 Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:03 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 200 | $220.21 | $44,042.00 |
DisclosureSEC source: 0001156375-21-000169 · wf-form4_163612457390592.xml · nonDerivative · entry 4 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,208 Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:03 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 300 | $220.21 | $66,062.40 |
DisclosureSEC source: 0001156375-21-000169 · wf-form4_163612457390592.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,008 Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:03 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 100 | $220.21 | $22,020.60 |
DisclosureSEC source: 0001156375-21-000169 · wf-form4_163612457390592.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,708 Read SEC document |
| November 04, 2021 Filed Nov 5, 2021 15:03 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 300 | $220.13 | $66,039.00 |
DisclosureSEC source: 0001156375-21-000169 · wf-form4_163612457390592.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,608 Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 16:20 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 23,816 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-21-000109 · wf-form4_163180922748879.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,308 Read SEC document |
| May 19, 2021 Filed May 21, 2021 17:13 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 29,000 | $210.83 | $6,114,070.00 |
DisclosureSEC source: 0001156375-21-000055 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,492 F1 · price: On May 19, 2021, Mr. Duffy sold an aggregate of 29,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices within a $1 range have been aggregated and the weighted average has been reported. The price ranges were $210.80 to $210.96. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:21 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 14,574 | $209.09 | $3,047,277.66 |
DisclosureSEC source: 0001156375-21-000029 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,492 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations in connection with the receipt of the performance share award. Read SEC document |
| March 15, 2021 Filed Mar 18, 2021 00:21 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 32,896 | $209.09 | $6,878,224.64 |
DisclosureSEC source: 0001156375-21-000029 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,066 F1 · shares: Represents shares earned from a 2017 performance share award based on the company's achievement of net income margin growth relative to the diversified financial services index of the S&P 500 and total shareholder return relative to the S&P 500 measured over 2018-2020. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 11,584 | $182.05 | $2,108,867.20 |
DisclosureSEC source: 0001156375-21-000001 · edgardoc.xml · nonDerivative · entry 7 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,170 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2020. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 3,948 | $182.05 | $718,733.40 |
DisclosureSEC source: 0001156375-21-000001 · edgardoc.xml · nonDerivative · entry 6 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,754 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2020. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,359 | $182.05 | $247,405.95 |
DisclosureSEC source: 0001156375-21-000001 · edgardoc.xml · nonDerivative · entry 5 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,702 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2020. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 3,038 | $182.05 | $553,067.90 |
DisclosureSEC source: 0001156375-21-000001 · edgardoc.xml · nonDerivative · entry 4 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,061 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2020. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 20 | $182.05 | $3,641.00 |
DisclosureSEC source: 0001156375-21-000001 · edgardoc.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,099 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2020. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,907 | $182.05 | $347,169.35 |
DisclosureSEC source: 0001156375-21-000001 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,119 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2020. Read SEC document |
| December 31, 2020 Filed Jan 4, 2021 21:38 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 568 | $182.05 | $103,404.40 |
DisclosureSEC source: 0001156375-21-000001 · edgardoc.xml · nonDerivative · entry 1 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,026 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 12/31/2020. Read SEC document |
| September 16, 2020 Filed Sep 17, 2020 22:00 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,345 | $170.20 | $228,919.00 |
DisclosureSEC source: 0001156375-20-000103 · edgardoc.xml · nonDerivative · entry 2 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,594 F1 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/16/2020. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 01:31 UTC | CME GROUP INC. CME · Entity 2909 | Tax withholdingCommon Stock Class A | 1,895 | $168.10 | $318,549.50 |
DisclosureSEC source: 0001156375-20-000091 · edgardoc.xml · nonDerivative · entry 3 DUFFY TERRENCE A · CIK 0001212809 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,171 F2 · shares: Mr. Duffy surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.